AVAL Q2 2025 Earnings Strong EPS Performance Drives Stock Gain CNS Q1 2026 Earnings EPS Misses Estimates by 34 Stock Declines Burford Capital Q1 2026 Earnings Massive EPS Miss with 5273 Surprise Drains Investor Confidence Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency ICON Q4 2025 Earnings EPS Miss Highlights Operational Challenges OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline